Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024
Cash Flows from Operating Activities
Net income	$ 22,579	$ 24,383	$ 24,977
Non-cash items included in net income
Depreciation and amortization	16,565	12,575	9,999
Deferred income taxes	5,902	(2,362)	(1,606)
Deferred compensation plan	1,884	1,943	1,875
Stock compensation expense	3,946	4,164	3,814
ESPP discount	335	218	194
Issuance of common shares as compensation	360	450	450
Loss on disposition of fixed assets	102	204	306
Allowance for credit losses	(7)	231	57
Inventory obsolescence reserve	(643)	528	(1,259)
Changes in certain assets and liabilities:
Accounts receivable	(10,401)	(22,100)	10,384
Inventories	(2,422)	(5,250)	6,310
Refundable income taxes	(3,359)	3,197	(77)
Accounts payable	6,611	16,306	(4,117)
Accrued expenses and other	2,696	3,631	(7,915)
Net cash flows provided by operating activities	44,148	38,118	43,392
Cash Flows from Investing Activities
Acquisition of Royston, EMI and CBH, net of cash acquired, and shares used in acquisition	(331,584)	(24,552)	(49,900)
Purchases of property, plant, and equipment	(5,142)	(3,465)	(5,388)
Proceeds from the sale of fixed assets	146	50	35
Net cash flows used in investing activities	(336,580)	(27,967)	(55,253)
Cash Flows from Financing Activities
Payments on long-term debt	(1,275,776)	(199,790)	(139,884)
Borrowings on long-term debt	1,483,149	194,117	158,912
Equity raise	98,109	0	0
Cash dividends paid	(6,461)	(5,970)	(5,737)
Shares withheld on employees' taxes	178	(509)	(447)
Payments on financing lease obligations	0	(340)	(324)
Proceeds from stock option exercises	4,356	1,061	1,788
Net cash flows provided by (used in) financing activities	303,555	(11,431)	14,308
Increase (decrease) in cash and cash equivalents	10,792	(653)	2,282
Cash and cash equivalents at beginning of period	3,457	4,110	1,828
Cash and cash equivalents at end of period	14,249	3,457	4,110
Change related to Foreign Currency	$ (331)	$ 627	$ (165)